Literature DB >> 23834233

Outcomes for people with atrial fibrillation in an Australian national audit of stroke care.

Nadine Andrew1, Monique Kilkenny, Dawn Harris, Chris Price, Dominique A Cadilhac.   

Abstract

BACKGROUND: Atrial fibrillation is associated with poorer outcomes poststroke. It is unclear how the quality of stroke care in hospitals influences outcomes in these patients. AIMS: The study aims to compare outcomes in stroke patients with and without atrial fibrillation and identify hospital processes of care associated with poor outcomes.
METHODS: Data were collected using retrospective, consecutive medical record audits from participating hospitals in the 2009 and 2011 National Stroke Foundation acute services audit program. Patient characteristics, stroke severity, and hospital management data were compared for those with and without atrial fibrillation. Multiple regression analyses for outcomes of in-hospital death, dependency at discharge (modified Rankin Score 3-5), and discharge destination were undertaken, adjusted for patient clustering by hospital.
RESULTS: Atrial fibrillation status was known for 5473 (80%) cases; 2049 had atrial fibrillation. Atrial fibrillation was independently associated with in-hospital mortality (aOR 1.46, 95% CI 1.06, 2.02). Management on a stroke unit (aOR 0.57, 95% CI 0.40, 0.80) and having a swallow assessment within 24 h (aOR 0.71, 95% CI 0.51, 0.98) were associated with increased survival among all stroke types, as was receiving aspirin within 48 h poststroke (aOR 0.65, 95% CI 0.44, 0.97), for patients with an ischemic stroke. Stroke patients with atrial fibrillation were less likely to receive important processes of care associated with reduced mortality.
CONCLUSIONS: Hospital processes of care can influence outcomes in stroke patients with atrial fibrillation. The greater in-hospital mortality experienced by stroke patients with atrial fibrillation may be attenuated by admission to a stroke unit, and for ischemic stroke, early administration of aspirin.
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization.

Entities:  

Keywords:  atrial fibrillation; outcomes; quality of care; stroke care; stroke delivery; stroke units

Mesh:

Year:  2013        PMID: 23834233     DOI: 10.1111/ijs.12087

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  6 in total

Review 1.  Clinical and Economic Implications of AF Related Stroke.

Authors:  Ali N Ali; Ahmed Abdelhafiz
Journal:  J Atr Fibrillation       Date:  2016-02-29

2.  Anticoagulation and population risk of stroke and death in incident atrial fibrillation: a population-based cohort study.

Authors:  Amy Y X Yu; Shaun Malo; Stephen Wilton; Ratika Parkash; Lawrence W Svenson; Michael D Hill
Journal:  CMAJ Open       Date:  2016-01-07

3.  Feasibility of a Clinical-Radiomics Model to Predict the Outcomes of Acute Ischemic Stroke.

Authors:  Yiran Zhou; Di Wu; Su Yan; Yan Xie; Shun Zhang; Wenzhi Lv; Yuanyuan Qin; Yufei Liu; Chengxia Liu; Jun Lu; Jia Li; Hongquan Zhu; Weiyin Vivian Liu; Huan Liu; Guiling Zhang; Wenzhen Zhu
Journal:  Korean J Radiol       Date:  2022-05-27       Impact factor: 7.109

4.  Long-Term Outcomes after Stroke in Elderly Patients with Atrial Fibrillation: A Hospital-Based Follow-Up Study in China.

Authors:  Yuguang Zhao; Chunying Zou; Cui Wang; Yongbo Zhang; Shuang Wang
Journal:  Front Aging Neurosci       Date:  2016-03-29       Impact factor: 5.750

5.  Effect of age on long-term outcomes after stroke with atrial fibrillation: a hospital-based follow-up study in China.

Authors:  Tao Wang; Bin Li; Hongfei Gu; Yongzhong Lou; Xianjia Ning; Jinghua Wang; Zhongping An
Journal:  Oncotarget       Date:  2017-02-25

6.  Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation.

Authors:  Andrea L Schaffer; Michael O Falster; David Brieger; Louisa R Jorm; Andrew Wilson; Melanie Hay; Kira Leeb; Sallie Pearson; Arthur Nasis
Journal:  J Am Heart Assoc       Date:  2019-12-04       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.